Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
<p>Supplemental Figure S8. A. Layout of tissues and B. Scanned whole-slide image of BN1021, normal human tissue microarray stained for CLDN6 expression showing no staining.</p>
Enregistré dans:
| Auteur principal: | |
|---|---|
| Autres auteurs: | , , , , , , , , , , , , , , , , , , |
| Publié: |
2025
|
| Sujets: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1849927633731584000 |
|---|---|
| author | Martina S.J. McDermott (15206951) |
| author2 | Neil A. O'Brien (15206954) Benjamin Hoffstrom (15206957) KeWei Gong (15206960) Ming Lu (15206963) Jun Zhang (15206966) Tong Luo (15206969) Min Liang (15206972) Weiping Jia (15206975) Jenny J. Hong (15206978) Kevin Chau (15206981) Simon Davenport (15206984) Bin Xie (15206987) Michael F. Press (15206990) Richard Panayiotou (15206993) Abram Handly-Santana (15206996) Joan S. Brugge (9710515) Leonard Presta (15206999) John Glaspy (15207002) Dennis J. Slamon (15047067) |
| author2_role | author author author author author author author author author author author author author author author author author author author |
| author_facet | Martina S.J. McDermott (15206951) Neil A. O'Brien (15206954) Benjamin Hoffstrom (15206957) KeWei Gong (15206960) Ming Lu (15206963) Jun Zhang (15206966) Tong Luo (15206969) Min Liang (15206972) Weiping Jia (15206975) Jenny J. Hong (15206978) Kevin Chau (15206981) Simon Davenport (15206984) Bin Xie (15206987) Michael F. Press (15206990) Richard Panayiotou (15206993) Abram Handly-Santana (15206996) Joan S. Brugge (9710515) Leonard Presta (15206999) John Glaspy (15207002) Dennis J. Slamon (15047067) |
| author_role | author |
| dc.creator.none.fl_str_mv | Martina S.J. McDermott (15206951) Neil A. O'Brien (15206954) Benjamin Hoffstrom (15206957) KeWei Gong (15206960) Ming Lu (15206963) Jun Zhang (15206966) Tong Luo (15206969) Min Liang (15206972) Weiping Jia (15206975) Jenny J. Hong (15206978) Kevin Chau (15206981) Simon Davenport (15206984) Bin Xie (15206987) Michael F. Press (15206990) Richard Panayiotou (15206993) Abram Handly-Santana (15206996) Joan S. Brugge (9710515) Leonard Presta (15206999) John Glaspy (15207002) Dennis J. Slamon (15047067) |
| dc.date.none.fl_str_mv | 2025-11-25T13:00:29Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30706643 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Figure_S8_from_Preclinical_Efficacy_of_the_Antibody_Drug_Conjugate_CLDN6_23-ADC_for_the_Treatment_of_CLDN6-Positive_Solid_Tumors/30706643 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Biological Agents & Therapies Antibody-drug conjugates Gynecological Cancers Endometrial cancer Ovarian cancer Translational Research |
| dc.title.none.fl_str_mv | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Supplemental Figure S8. A. Layout of tissues and B. Scanned whole-slide image of BN1021, normal human tissue microarray stained for CLDN6 expression showing no staining.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_c3d8b0cb3133e64e8d9d57d0cd8b52af |
| identifier_str_mv | 10.1158/1078-0432.30706643 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30706643 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid TumorsMartina S.J. McDermott (15206951)Neil A. O'Brien (15206954)Benjamin Hoffstrom (15206957)KeWei Gong (15206960)Ming Lu (15206963)Jun Zhang (15206966)Tong Luo (15206969)Min Liang (15206972)Weiping Jia (15206975)Jenny J. Hong (15206978)Kevin Chau (15206981)Simon Davenport (15206984)Bin Xie (15206987)Michael F. Press (15206990)Richard Panayiotou (15206993)Abram Handly-Santana (15206996)Joan S. Brugge (9710515)Leonard Presta (15206999)John Glaspy (15207002)Dennis J. Slamon (15047067)CancerTherapeutic Research and DevelopmentBiological Agents & TherapiesAntibody-drug conjugatesGynecological CancersEndometrial cancerOvarian cancerTranslational Research<p>Supplemental Figure S8. A. Layout of tissues and B. Scanned whole-slide image of BN1021, normal human tissue microarray stained for CLDN6 expression showing no staining.</p>2025-11-25T13:00:29ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30706643https://figshare.com/articles/figure/Figure_S8_from_Preclinical_Efficacy_of_the_Antibody_Drug_Conjugate_CLDN6_23-ADC_for_the_Treatment_of_CLDN6-Positive_Solid_Tumors/30706643CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307066432025-11-25T13:00:29Z |
| spellingShingle | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors Martina S.J. McDermott (15206951) Cancer Therapeutic Research and Development Biological Agents & Therapies Antibody-drug conjugates Gynecological Cancers Endometrial cancer Ovarian cancer Translational Research |
| status_str | publishedVersion |
| title | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| title_full | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| title_fullStr | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| title_full_unstemmed | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| title_short | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| title_sort | Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors |
| topic | Cancer Therapeutic Research and Development Biological Agents & Therapies Antibody-drug conjugates Gynecological Cancers Endometrial cancer Ovarian cancer Translational Research |